Clinical Trials Directory

A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases

RATIONALE: Radiation therapy uses high energy x-rays to kill tumor cells. PURPOSE: This phase II trial is studying how well avoiding the hippocampus during whole-brain radiation therapy works in treating patients with brain metastases.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • other : questionnaire administration
  • other : laboratory biomarker analysis
  • procedure : cognitive assessment
  • procedure : quality-of-life assessment
  • radiation : whole-brain radiation therapy
  • radiation : intensity-modulated radiation therapy

Phase: Phase 2


Ages Eligible For Study:

18 Years - N/A

External Links

Explore related trials

Contact information

Primary Contact:

Jacob Wynne 6507238843

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: